Parnell Living Science

United States
Overland Park, Kansas, United States, 66211

Company profile

Parnell Living Science company profile

Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter. With a world-class, FDA-accredited manufacturing facility in Sydney and operations in the United States, Canada, Middle East and Asia-Pacific, Parnell is committed to continued development of innovative products at the highest standard. Parnell currently markets products for companion, performance and production animals enhanced with proprietary software platforms designed to improve compliance and clinical outcomes. Parnell is poised to bring several new products to market over the next five years addressing up to twelve indications and needs, with a particular focus on the companion animal sector. At Parnell, we believe the combination of our current product portfolio, pipeline of product candidates and business solutions position us to become a leading innovator in animal health. Our value-added approach establishes us as a business partner with our customers, not a commodity provider. That is the Parnell difference.

Business identity

Contact email
[email protected]
Phone number
800-887-2763
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
1968-01-01, Year

Headquarters

Postal code
66211
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Last funding
Post IPO Debt / 2021-02-01
Investors
3
Lead investors
2
Founders
1
Articles
2
Exited on
2014-06-18

Founders and investors

Founders

Robert Joseph

Lead investors

SWK HoldingsWhite Oak Healthcare Finance

Investors

Armentum PartnersSWK HoldingsWhite Oak Healthcare Finance